# BIOMAX AI v2.0 ‚Äî Personal Health Operating System

**–ú—É–ª—å—Ç–∏–∞–≥–µ–Ω—Ç–Ω–∞—è –ø–ª–∞—Ç—Ñ–æ—Ä–º–∞ –¥–ª—è —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è –∑–¥–æ—Ä–æ–≤—å–µ–º —Å AI-–∞–≥–µ–Ω—Ç–∞–º–∏**

- üéØ **15 —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö AI-–∞–≥–µ–Ω—Ç–æ–≤** –¥–ª—è –∞–Ω–∞–ª–∏–∑–∞ –≤—Å–µ—Ö –∞—Å–ø–µ–∫—Ç–æ–≤ –∑–¥–æ—Ä–æ–≤—å—è
- üìä **100+ –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏–π** —Å —É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞–º–∏, –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏—è–º–∏ –∏ —Å–µ—Ä–≤–∏—Å–∞–º–∏ –¥–∞–Ω–Ω—ã—Ö
- üß† **Custom RAG** ‚Äî –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—å—Å–∫–∞—è –±–∞–∑–∞ –∑–Ω–∞–Ω–∏–π —Å –ø—Ä–æ—Ç–æ–∫–æ–ª–∞–º–∏ –∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º–∏
- üîí **152-–§–ó compliance** ‚Äî –ø–æ–ª–Ω–∞—è –∑–∞—â–∏—Ç–∞ –ø–µ—Ä—Å–æ–Ω–∞–ª—å–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö
- üá∑üá∫ **–õ–æ–∫–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–∞ –¥–ª—è –†–æ—Å—Å–∏–∏** ‚Äî –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è —Å —Ä–æ—Å—Å–∏–π—Å–∫–∏–º–∏ –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏—è–º–∏ –∏ LLM

---

## üìö –ö–∞—Ç–∞–ª–æ–≥ –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –ø—Ä–æ–µ–∫—Ç–∞

–í—Å–µ –¥–æ–∫—É–º–µ–Ω—Ç—ã –ø—Ä–æ–µ–∫—Ç–∞ –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞–Ω—ã –ø–æ **—Ç–∏–ø–∞–º** –∏ **—Ñ–∞–∑–∞–º —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏**. –ò—Å–ø–æ–ª—å–∑—É–π—Ç–µ —ç—Ç–æ—Ç –∫–∞—Ç–∞–ª–æ–≥ –¥–ª—è –Ω–∞–≤–∏–≥–∞—Ü–∏–∏ –ø–æ –ø—Ä–æ–µ–∫—Ç—É.

### üéØ –ë—ã—Å—Ç—Ä—ã–π —Å—Ç–∞—Ä—Ç (5-10 –º–∏–Ω—É—Ç)

–ù–∞—á–Ω–∏—Ç–µ –æ—Ç—Å—é–¥–∞, –µ—Å–ª–∏ –Ω—É–∂–µ–Ω –±—ã—Å—Ç—Ä—ã–π –æ–±–∑–æ—Ä –ø—Ä–æ–µ–∫—Ç–∞:

- **[Project Brief](context/project-brief.yaml)** ‚Äî –æ—Å–Ω–æ–≤–Ω–æ–π –¥–æ–∫—É–º–µ–Ω—Ç –ø—Ä–æ–µ–∫—Ç–∞
  - –í–∏–¥–µ–Ω–∏–µ –∏ –ø—Ä–æ–±–ª–µ–º—ã
  - –¶–µ–ª–µ–≤–∞—è –∞—É–¥–∏—Ç–æ—Ä–∏—è –∏ —Ä—ã–Ω–æ–∫
  - –û—Å–Ω–æ–≤–Ω—ã–µ —Ñ—É–Ω–∫—Ü–∏–∏ (7 P0 features)
  - Tech stack –∏ MVP-–º–æ–¥—É–ª–∏
  - –†–µ—à–µ–Ω–∏—è –∏ —Å–ª–µ–¥—É—é—â–∏–µ —à–∞–≥–∏

- **[Project Brief Summary](context/summaries/project-brief-summary.md)** ‚Äî 1-—Å—Ç—Ä–∞–Ω–∏—á–Ω–æ–µ —Ä–µ–∑—é–º–µ
  - –û–¥–Ω–∞ —Å—Ç—Ä–æ–∫–∞ –æ–ø–∏—Å–∞–Ω–∏—è
  - –ò–Ω–Ω–æ–≤–∞—Ü–∏–∏ –∏ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞
  - –¶–µ–ª–µ–≤—ã–µ —Å–µ–≥–º–µ–Ω—Ç—ã

---

## üìã –ü–û –¢–ò–ü–ê–ú –î–û–ö–£–ú–ï–ù–¢–û–í

### 1Ô∏è‚É£ –°–¢–†–ê–¢–ï–ì–ò–Ø –ò –ü–†–û–î–£–ö–¢ (7 –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤)

#### üìÑ –û—Å–Ω–æ–≤–Ω—ã–µ –¥–æ–∫—É–º–µ–Ω—Ç—ã

| ‚Ññ | –î–æ–∫—É–º–µ–Ω—Ç | –†–∞–∑–º–µ—Ä | –û–ø–∏—Å–∞–Ω–∏–µ |
|---|----------|--------|---------|
| 1 | [Vision Statement](docs/discovery/vision.md) | 457 —Å—Ç—Ä–æ–∫ | **–í–∏–¥–µ–Ω–∏–µ –ø—Ä–æ–¥—É–∫—Ç–∞**: –ø—Ä–æ–±–ª–µ–º—ã, —Ä–µ—à–µ–Ω–∏–µ, —É–Ω–∏–∫–∞–ª—å–Ω–∞—è —Ü–µ–Ω–Ω–æ—Å—Ç—å, —É—Å–ø–µ—Ö–∞ –º–µ—Ç—Ä–∏–∫–∏ |
| 2 | [Product Requirements Document (PRD)](docs/discovery/prd.md) | 568 —Å—Ç—Ä–æ–∫ | **27 —Ñ—É–Ω–∫—Ü–∏–æ–Ω–∞–ª—å–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π P0** + personas + goals + roadmap outline |
| 3 | [User Stories](docs/discovery/user-stories.md) | 1,356 —Å—Ç—Ä–æ–∫ | **21 user story** —Å acceptance criteria –≤ —Ñ–æ—Ä–º–∞—Ç–µ Gherkin; 15 –∞–≥–µ–Ω—Ç–æ–≤ |
| 4 | [Personas](docs/discovery/personas.md) | ~350 —Å—Ç—Ä–æ–∫ | **3 –ø–æ–¥—Ä–æ–±–Ω—ã–µ persona** —Å JTBD, pain points, willingness to pay |
| 5 | [Roadmap](docs/discovery/roadmap.md) | ~300 —Å—Ç—Ä–æ–∫ | **–¢—Ä—ë—Ö—Ñ–∞–∑–Ω—ã–π roadmap**: MVP ‚Üí Growth ‚Üí Scale —Å —Ç–∞–π–º–ª–∞–π–Ω–∞–º–∏ |
| 6 | [Competitive Analysis](docs/discovery/competitive-analysis.md) | 875 —Å—Ç—Ä–æ–∫ | **8 –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–æ–≤** (InsideTracker, Levels, Oura, WHOOP, Gyroscope –∏ –¥—Ä.) |
| 7 | [Extended Research](docs/BIOMAX_AI_v2_Extended_Research%20(1).md) | 1,284 —Å—Ç—Ä–æ–∫ | **–ì–ª—É–±–æ–∫–∏–π market research** ‚Äî biohacking —Ç—Ä–µ–Ω–¥—ã, –Ω–∞—É—á–Ω–∞—è –±–∞–∑–∞, inspiration |

#### üìã –†–µ–∑—é–º–µ –¥–ª—è –±—ã—Å—Ç—Ä–æ–≥–æ –æ–∑–Ω–∞–∫–æ–º–ª–µ–Ω–∏—è

| –î–æ–∫—É–º–µ–Ω—Ç | –†–∞–∑–º–µ—Ä | –î–ª—è –∫–æ–≥–æ |
|----------|--------|----------|
| [PRD Summary](context/summaries/prd-summary.md) | 75 —Å—Ç—Ä–æ–∫ | –ë—ã—Å—Ç—Ä—ã–π –æ–±–∑–æ—Ä –æ—Å–Ω–æ–≤–Ω—ã—Ö —Ñ–∏—á |
| [Personas Summary](context/summaries/personas-summary.yaml) | 50 —Å—Ç—Ä–æ–∫ | 3 personas –Ω–∞ –æ–¥–Ω–æ–π —Å—Ç—Ä–∞–Ω–∏—Ü–µ |
| [Roadmap Summary](context/summaries/roadmap-summary.yaml) | 40 —Å—Ç—Ä–æ–∫ | –¢–∞–π–º–ª–∞–π–Ω —Ñ–∞–∑ –≤ YAML |

---

### 2Ô∏è‚É£ –ë–ò–ó–ù–ï–° –ò –ú–û–î–ï–õ–¨ (4 –¥–æ–∫—É–º–µ–Ω—Ç–∞)

| ‚Ññ | –î–æ–∫—É–º–µ–Ω—Ç | –†–∞–∑–º–µ—Ä | –û–ø–∏—Å–∞–Ω–∏–µ |
|---|----------|--------|---------|
| 1 | [Business Model](docs/business/business-model.md) | ~300 —Å—Ç—Ä–æ–∫ | **5 pricing tiers** (Free ‚Üí Longevity Elite), revenue streams, unit economics |
| 2 | [Requirements (FURPS+)](docs/business/requirements-furps.md) | ~400 —Å—Ç—Ä–æ–∫ | **218 —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π**: Functional, Usability, Reliability, Performance, Supportability |
| 3 | [Use Cases](docs/business/use-cases.md) | ~200 —Å—Ç—Ä–æ–∫ | **–û—Å–Ω–æ–≤–Ω—ã–µ —é–∑-–∫–µ–π—Å—ã** –ø–æ personas |

#### üìã –†–µ–∑—é–º–µ

| –î–æ–∫—É–º–µ–Ω—Ç | –†–∞–∑–º–µ—Ä |
|----------|--------|
| [Business Model Summary](context/summaries/business-model-summary.md) | 55 —Å—Ç—Ä–æ–∫ |
| [Requirements Summary (FURPS+)](context/summaries/requirements-furps-summary.yaml) | 60 —Å—Ç—Ä–æ–∫ |
| [Use Cases Summary](context/summaries/use-cases-summary.yaml) | 50 —Å—Ç—Ä–æ–∫ |

---

### 3Ô∏è‚É£ –ü–†–ê–í–û–í–´–ï –ò –†–ï–ì–£–õ–Ø–¢–û–†–ù–´–ï (3 –¥–æ–∫—É–º–µ–Ω—Ç–∞)

| ‚Ññ | –î–æ–∫—É–º–µ–Ω—Ç | –†–∞–∑–º–µ—Ä | –û–ø–∏—Å–∞–Ω–∏–µ |
|---|----------|--------|---------|
| 1 | [152-–§–ó Compliance](docs/discovery/legal/152-fz-compliance.md) | 461 —Å—Ç—Ä–æ–∫ | **–†–æ—Å—Å–∏–π—Å–∫–æ–µ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ**: —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ —Ö—Ä–∞–Ω–µ–Ω–∏—é –¥–∞–Ω–Ω—ã—Ö, –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω—ã–µ —Ç–æ—á–∫–∏ |
| 2 | [Wellness vs Medicine](docs/discovery/legal/wellness-vs-medicine.md) | ~250 —Å—Ç—Ä–æ–∫ | **–ü—Ä–∞–≤–æ–≤—ã–µ –≥—Ä–∞–Ω–∏—Ü—ã**: —á—Ç–æ –º–æ–∂–µ–º/–Ω–µ –º–æ–∂–µ–º, disclaimers, positioning |
| 3 | [Legal Summary](docs/discovery/legal/legal-summary.md) | 371 —Å—Ç—Ä–æ–∫ | **–†–µ–∑—é–º–µ —Ä–∏—Å–∫–æ–≤** –∏ compliance checklist |

#### üìÑ –î–æ–ø. –º–∞—Ç–µ—Ä–∏–∞–ª—ã

- [Disclaimers Templates](docs/discovery/legal/disclaimers-templates.md) ‚Äî –≥–æ—Ç–æ–≤—ã–µ —à–∞–±–ª–æ–Ω—ã –¥–∏—Å–∫–ª–µ–π–º–µ—Ä–æ–≤

---

### 4Ô∏è‚É£ –¢–ï–•–ù–ò–ß–ï–°–ö–ê–Ø –ê–†–•–ò–¢–ï–ö–¢–£–†–ê (3 –¥–æ–∫—É–º–µ–Ω—Ç–∞)

| ‚Ññ | –î–æ–∫—É–º–µ–Ω—Ç | –†–∞–∑–º–µ—Ä | –û–ø–∏—Å–∞–Ω–∏–µ |
|---|----------|--------|---------|
| 1 | [API Integrations](docs/discovery/technical/api-integrations.md) | ~400 —Å—Ç—Ä–æ–∫ | **100+ API** –ø–æ –∫–∞—Ç–µ–≥–æ—Ä–∏—è–º (wearables, CGM, labs, genomics, microbiome) |
| 2 | [LangGraph Architecture](docs/discovery/technical/langraph-architecture.md) | ~300 —Å—Ç—Ä–æ–∫ | **–ú—É–ª—å—Ç–∏–∞–≥–µ–Ω—Ç–Ω–∞—è –∞—Ä—Ö–∏—Ç–µ–∫—Ç—É—Ä–∞**: 15 –∞–≥–µ–Ω—Ç–æ–≤, orchestration, state management |
| 3 | [Kubernetes Infrastructure](docs/discovery/technical/kubernetes-infrastructure.md) | ~250 —Å—Ç—Ä–æ–∫ | **K8s deployment**, 152-–§–ó considerations, scalability |

#### üìÑ Tech Stack Preview

```yaml
Backend:
  - API Gateway: FastAPI + Kong
  - Agent Orchestrator: LangGraph / CrewAI
  - RAG Pipeline: LlamaIndex + Qdrant
  - Databases: PostgreSQL, ClickHouse, Qdrant, Neo4j
  
Frontend:
  - Mobile: Flutter (iOS + Android)
  - Web: Next.js + Tailwind
  - Telegram: aiogram 3.x
  - Voice: Whisper + TTS

LLM:
  - International: GPT-4o, Claude
  - Russian: GigaChat, YandexGPT
```

---

### 5Ô∏è‚É£ –ê–ù–ê–õ–ò–¢–ò–ö–ê –ò –ú–ï–¢–†–ò–ö–ò (2 –¥–æ–∫—É–º–µ–Ω—Ç–∞)

| ‚Ññ | –î–æ–∫—É–º–µ–Ω—Ç | –†–∞–∑–º–µ—Ä | –û–ø–∏—Å–∞–Ω–∏–µ |
|---|----------|--------|---------|
| 1 | [Metrics Framework](docs/analytics/metrics-framework.md) | ~250 —Å—Ç—Ä–æ–∫ | **AARRR metrics** + health outcome KPIs + event taxonomy |
| 2 | [Tracking Plan](docs/analytics/tracking-plan.md) | ~300 —Å—Ç—Ä–æ–∫ | **Event taxonomy**, dashboards, data architecture, funnel definitions |

#### üìã –†–µ–∑—é–º–µ

| –î–æ–∫—É–º–µ–Ω—Ç | –†–∞–∑–º–µ—Ä |
|----------|--------|
| [Metrics Summary](context/summaries/metrics-framework-summary.yaml) | 50 —Å—Ç—Ä–æ–∫ |
| [Tracking Plan Summary](context/summaries/tracking-plan-summary.yaml) | 50 —Å—Ç—Ä–æ–∫ |

---

### 6Ô∏è‚É£ –î–ò–ó–ê–ô–ù –ò UX (2 –¥–æ–∫—É–º–µ–Ω—Ç–∞)

| ‚Ññ | –î–æ–∫—É–º–µ–Ω—Ç | –†–∞–∑–º–µ—Ä | –û–ø–∏—Å–∞–Ω–∏–µ |
|---|----------|--------|---------|
| 1 | [User Flows](docs/design/user-flows.md) | ~250 —Å—Ç—Ä–æ–∫ | **5 –æ—Å–Ω–æ–≤–Ω—ã—Ö flow**: Onboarding, Dashboard, RAG, Recommendations, Reports |
| 2 | [UX Research](docs/discovery/ux-research.md) | ~300 —Å—Ç—Ä–æ–∫ | **Findings** –ø–æ –±–∏–æ—Ö–∞–∫–µ—Ä–∞–º –∏ health optimizers, insights, accessibility |

#### üìÑ –î–æ–ø. –º–∞—Ç–µ—Ä–∏–∞–ª—ã

- [Customer Journey Map](docs/design/cjm.md) ‚Äî CJM –¥–ª—è –∫–∞–∂–¥–æ–π personas

#### üìã –†–µ–∑—é–º–µ

| –î–æ–∫—É–º–µ–Ω—Ç | –†–∞–∑–º–µ—Ä |
|----------|--------|
| [UX Research Summary](context/summaries/ux-research-summary.yaml) | 50 —Å—Ç—Ä–æ–∫ |

---

### 7Ô∏è‚É£ –ú–ê–†–ö–ï–¢–ò–ù–ì –ò –ü–ê–†–¢–ù–Å–†–°–¢–í–ê (4 –¥–æ–∫—É–º–µ–Ω—Ç–∞)

| ‚Ññ | –î–æ–∫—É–º–µ–Ω—Ç | –†–∞–∑–º–µ—Ä | –û–ø–∏—Å–∞–Ω–∏–µ |
|---|----------|--------|---------|
| 1 | [Marketing Strategy](docs/marketing/strategy.md) | ~250 —Å—Ç—Ä–æ–∫ | **Go-to-Market strategy** –¥–ª—è —Ç—Ä—ë—Ö personas |
| 2 | [Launch Plan](docs/marketing/launch-plan.md) | ~200 —Å—Ç—Ä–æ–∫ | **–§–∞–∑–æ–≤—ã–π launch**: Beta ‚Üí Public ‚Üí Growth |
| 3 | [Content Plan](docs/marketing/content-plan.md) | ~200 —Å—Ç—Ä–æ–∫ | **Content roadmap**: –±–ª–æ–≥, —Å–æ—Ü–∏–∞–ª, email, events |
| 4 | [Partnership Page](docs/partnership-page.md) | 453 —Å—Ç—Ä–æ–∫ | **Landing page –¥–ª—è –ø–∞—Ä—Ç–Ω—ë—Ä–æ–≤** (–ª–∞–±—ã, –≤–µ–Ω–¥–æ—Ä—ã, –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏–∏) |
| 5 | [Channel Strategy](docs/marketing/channel-strategy.md) | ~150 —Å—Ç—Ä–æ–∫ | **5 –æ—Å–Ω–æ–≤–Ω—ã—Ö –∫–∞–Ω–∞–ª–æ–≤** —Å –º–µ—Ç—Ä–∏–∫–∞–º–∏ |

---

### 8Ô∏è‚É£ RESEARCH –ò MARKET INSIGHTS (1 –¥–æ–∫—É–º–µ–Ω—Ç)

| ‚Ññ | –î–æ–∫—É–º–µ–Ω—Ç | –†–∞–∑–º–µ—Ä | –û–ø–∏—Å–∞–Ω–∏–µ |
|---|----------|--------|---------|
| 1 | [Market Research](docs/research/market-research.md) | ~150 —Å—Ç—Ä–æ–∫ | **–†–∞–∑–º–µ—Ä —Ä—ã–Ω–∫–∞**, —Ç—Ä–µ–Ω–¥—ã, opportunity gaps |

---

## üìÖ –ü–û –§–ê–ó–ê–ú –ü–†–û–ï–ö–¢–ê

### DISCOVERY ‚úÖ –ó–ê–í–ï–†–®–ï–ù–û (2026-01-26)

**–°—Ç–∞—Ç—É—Å**: Phase complete, all 7 actions delivered ‚úÖ

#### üéØ Deliverables (32 –∞—Ä—Ç–µ—Ñ–∞–∫—Ç–∞)

**Primary Documents (18)**
- ‚úÖ Vision + PRD + User Stories
- ‚úÖ Business Model + Requirements (FURPS+)
- ‚úÖ Legal (152-–§–ó compliance)
- ‚úÖ Technical Architecture (LangGraph, K8s, APIs)
- ‚úÖ Competitive Analysis (8 competitors)
- ‚úÖ UX Research (10 interviews)
- ‚úÖ Marketing & Partnerships
- ‚úÖ Analytics & Metrics

**Summaries (9)**
- ‚úÖ Project Brief Summary
- ‚úÖ PRD Summary
- ‚úÖ Personas Summary
- ‚úÖ Requirements Summary
- ‚úÖ Metrics Framework Summary
- ‚úÖ Roadmap Summary
- ‚úÖ Use Cases Summary
- ‚úÖ UX Research Summary
- ‚úÖ Business Model Summary

**Checkpoints (5)**
- ‚úÖ 2026-01-26-requirements-furps.md
- ‚úÖ 2026-01-26-tracking-plan.md
- ‚úÖ 2026-01-26-use-cases.md
- ‚úÖ 2026-01-26-ux-research.md
- ‚úÖ 2026-01-26-discovery-phase-complete.md

**Phase Metrics**
- Requirements: 218 (P0: 156, P1: 56, P2: 6)
- User Stories: 21 (all with AC in Gherkin)
- Competitors Analyzed: 8
- AI Agents Mapped: 15
- API Integrations: 100+
- Quality Gate: 10/10 ‚úÖ

#### üìñ Discovery Documents Index

```
/context/
‚îú‚îÄ‚îÄ project-brief.yaml ..................... Master doc (448 lines)
‚îú‚îÄ‚îÄ summaries/ ............................ Quick reference (9 docs, ~500 lines)
‚îú‚îÄ‚îÄ checkpoints/ ......................... Progress tracking (5 docs)

/docs/discovery/
‚îú‚îÄ‚îÄ vision.md ............................ Vision statement (457 lines)
‚îú‚îÄ‚îÄ prd.md .............................. Product Requirements (568 lines)
‚îú‚îÄ‚îÄ user-stories.md ..................... User Stories √ó 21 (1,356 lines)
‚îú‚îÄ‚îÄ personas.md ......................... Personas √ó 3
‚îú‚îÄ‚îÄ roadmap.md .......................... Phase-based roadmap
‚îú‚îÄ‚îÄ competitive-analysis.md ............ Competitors (8) ‚Äî 875 lines
‚îú‚îÄ‚îÄ ux-research.md ..................... UX Findings, insights, accessibility
‚îú‚îÄ‚îÄ technical/
‚îÇ   ‚îú‚îÄ‚îÄ api-integrations.md ........... 100+ API catalog
‚îÇ   ‚îú‚îÄ‚îÄ langraph-architecture.md ..... Multi-agent design
‚îÇ   ‚îî‚îÄ‚îÄ kubernetes-infrastructure.md  K8s + 152-–§–ó
‚îú‚îÄ‚îÄ legal/
‚îÇ   ‚îú‚îÄ‚îÄ 152-fz-compliance.md ......... Russian law
‚îÇ   ‚îú‚îÄ‚îÄ wellness-vs-medicine.md ..... Legal boundaries
‚îÇ   ‚îî‚îÄ‚îÄ legal-summary.md ............ Risk assessment

/docs/business/
‚îú‚îÄ‚îÄ business-model.md ............... 5 pricing tiers
‚îú‚îÄ‚îÄ requirements-furps.md ........... 218 requirements
‚îî‚îÄ‚îÄ use-cases.md ................... Key use cases

/docs/analytics/
‚îú‚îÄ‚îÄ metrics-framework.md ........... AARRR + KPIs
‚îî‚îÄ‚îÄ tracking-plan.md .............. Event taxonomy

/docs/design/
‚îú‚îÄ‚îÄ user-flows.md ................. 5 core flows
‚îú‚îÄ‚îÄ cjm.md ........................ Customer Journey Map

/docs/marketing/
‚îú‚îÄ‚îÄ strategy.md ................... Go-to-Market
‚îú‚îÄ‚îÄ launch-plan.md ................ Launch timeline
‚îú‚îÄ‚îÄ channel-strategy.md ........... 5 channels
‚îî‚îÄ‚îÄ content-plan.md ............... Content roadmap

/docs/
‚îú‚îÄ‚îÄ partnership-page.md ........... Partner landing page
‚îú‚îÄ‚îÄ research/
‚îÇ   ‚îî‚îÄ‚îÄ market-research.md ....... Market size & trends
‚îî‚îÄ‚îÄ BIOMAX_AI_v2_Extended_Research (1).md ... Deep research (1,284 lines)
```

**Reference**: [DISCOVERY_COMPLETION_REPORT.md](DISCOVERY_COMPLETION_REPORT.md)

---

### DESIGN (UPCOMING)

**Timeline**: ~6 weeks (estimated start 2026-01-27)

**Expected Deliverables**:
- [ ] Design System (60+ components, WCAG A compliance)
- [ ] Wireframes (all user flows, 5+ screens per persona)
- [ ] High-Fidelity Prototypes (Figma, interactive core features)
- [ ] Detailed LangGraph Design (15 agents, orchestration)
- [ ] Database Schema v1 (relationships, 152-–§–ó constraints)
- [ ] API Contract Specs (OpenAPI for all integrations)
- [ ] Technical Deep-Dives (per-agent specifications)
- [ ] Security Threat Model (data protection strategy)
- [ ] Accessibility Plan (WCAG A roadmap)

**Location**: `/docs/design/` (TBD)

---

### DEVELOPMENT (FUTURE)

**Estimated Timeline**: Phases MVP ‚Üí Growth ‚Üí Scale

**Expected Artifacts**:
- Backend Implementation (FastAPI, LangGraph orchestrator)
- Frontend (Flutter, Next.js, Telegram Bot)
- Database Migrations (PostgreSQL, ClickHouse, Qdrant)
- Integration Implementations (100+ APIs)
- Testing & QA (unit, integration, E2E)
- DevOps & Deployment (Kubernetes, CI/CD)

**Location**: `/src/`, `/backend/`, `/frontend/` (TBD)

---

## üéØ 15 –°–ü–ï–¶–ò–ê–õ–ò–ó–ò–†–û–í–ê–ù–ù–´–• AI-–ê–ì–ï–ù–¢–û–í

–í–æ—Ç –æ—Å–Ω–æ–≤–Ω—ã–µ –∞–≥–µ–Ω—Ç—ã, –¥–µ—Ç–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –≤ –¥–æ–∫—É–º–µ–Ω—Ç–∞—Ö:

| ‚Ññ | –ê–≥–µ–Ω—Ç | –†–æ–ª—å | –û—Å–Ω–æ–≤–Ω—ã–µ User Stories | –ò–Ω—Ç–µ–≥—Ä–∞—Ü–∏–∏ |
|----|-------|------|----------------------|-----------|
| 1 | **Orchestrator** | –ö–æ–æ—Ä–¥–∏–Ω–∞—Ü–∏—è, –º–∞—Ä—à—Ä—É—Ç–∏–∑–∞—Ü–∏—è | Multi-agent routing | LangGraph |
| 2 | **Coach** | –ú–æ—Ç–∏–≤–∞—Ü–∏—è, —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ | Actionable insights, habits | Telegram, notifications |
| 3 | **Sleep** | –ê–Ω–∞–ª–∏–∑ —Å–Ω–∞, —Ü–∏—Ä–∫–∞–¥–Ω—ã–µ —Ä–∏—Ç–º—ã | Sleep patterns, recommendations | Oura Ring API |
| 4 | **Nutrition** | –î–∏–µ—Ç—ã, –Ω—É—Ç—Ä–∏–≥–µ–Ω–æ–º–∏–∫–∞ | Personalized diet, supplements | MyFitnessPal API |
| 5 | **Longevity** | –ë–∏–æ–≤–æ–∑—Ä–∞—Å—Ç, –∞–Ω—Ç–∏—Å—Ç–∞—Ä–µ–Ω–∏–µ | Epigenetic age, protocols | TruDiagnostic, test uploads |
| 6 | **Lab Interpreter** | –ê–Ω–∞–ª–∏–∑—ã –∫—Ä–æ–≤–∏ | Blood test insights | INVITRO API / PDF parser |
| 7 | **Safety** | –ö–æ–Ω—Ç—Ä–ø–æ–∫–∞–∑–∞–Ω–∏—è, red flags | Contraindications, warnings | DrugBank API |
| 8 | **Data Scientist** | –ü–∞—Ç—Ç–µ—Ä–Ω—ã, –∫–æ—Ä—Ä–µ–ª—è—Ü–∏–∏ | Pattern analysis, trends | Internal data synthesis |
| 9 | **Genomics** | –î–ù–ö, SNP, –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∞—Ü–∏—è | DNA insights, recommendations | 23andMe raw data import |
| 10 | **Research** | –ü–æ–∏—Å–∫ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π | Literature synthesis | PubMed API |
| 11 | **Mental Health** | –°—Ç—Ä–µ—Å—Å, mood tracking | Mood tracking, CBT | PHQ-9/GAD-7 surveys |
| 12 | **Fitness** | –¢—Ä–µ–Ω–∏—Ä–æ–≤–∫–∏, –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ | Workout analysis, recovery | Strava API |
| 13 | **Integration** | –°–∏–Ω—Ç–µ–∑ –¥–∞–Ω–Ω—ã—Ö, cross-agent | Data synthesis, correlations | Internal orchestration |
| 14 | **Custom Protocol** | –ü–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏–µ –º–µ—Ç–æ–¥–∏–∫–∏ | RAG indexing, file upload | PDF/MD file upload |
| 15 | **Cognitive** | –ù–æ–æ—Ç—Ä–æ–ø—ã, –Ω–µ–π—Ä–æ—Ñ–∏–¥–±—ç–∫ | Cognitive enhancement | Cambridge Brain Sciences |

**–î–µ—Ç–∞–ª—å–Ω–æ –æ–ø–∏—Å–∞–Ω—ã –≤**: [LangGraph Architecture](docs/discovery/technical/langraph-architecture.md)

---

## üìä –ö–õ–Æ–ß–ï–í–´–ï –ú–ï–¢–†–ò–ö–ò

### –ü—Ä–æ–µ–∫—Ç–Ω—ã–µ –ú–µ—Ç—Ä–∏–∫–∏

| –ú–µ—Ç—Ä–∏–∫–∞ | –ó–Ω–∞—á–µ–Ω–∏–µ | –°—Ç–∞—Ç—É—Å |
|---------|----------|--------|
| **Total Artifacts** | 32 | ‚úÖ –ü—Ä–µ–≤—ã—à–µ–Ω–æ (target 20) |
| **Primary Documents** | 18 | ‚úÖ –ü—Ä–µ–≤—ã—à–µ–Ω–æ (target 10) |
| **Requirements** | 218 | ‚úÖ –ü—Ä–µ–≤—ã—à–µ–Ω–æ (target 150) |
| **Quality Gate** | 10/10 | ‚úÖ Passed |
| **Critical Blockers** | 0 | ‚úÖ None |

### Business Metrics (M12 Projections)

| –ú–µ—Ç—Ä–∏–∫–∞ | –ü—Ä–æ–≥–Ω–æ–∑ |
|---------|---------|
| **Total Users** | 150,000 |
| **Paying Users** | 10,000 |
| **Conversion Rate** | 6.7% |
| **ARPU** | 1,200 ‚ÇΩ |
| **MRR** | 15M ‚ÇΩ |
| **LTV/CAC** | 5x |

**–î–µ—Ç–∞–ª—å–Ω–æ**: [Metrics Framework](docs/analytics/metrics-framework.md) & [Tracking Plan](docs/analytics/tracking-plan.md)

---

## üöÄ –ë–´–°–¢–†–ê–Ø –ù–ê–í–ò–ì–ê–¶–ò–Ø

### –î–ª—è —Ä–∞–∑–Ω—ã—Ö —Ä–æ–ª–µ–π

**üë§ Product Manager**
1. [Project Brief](context/project-brief.yaml) ‚Äî overview
2. [PRD](docs/discovery/prd.md) ‚Äî requirements
3. [User Stories](docs/discovery/user-stories.md) ‚Äî acceptance criteria
4. [Roadmap](docs/discovery/roadmap.md) ‚Äî timeline

**üë®‚Äçüíº Business Lead**
1. [Business Model](docs/business/business-model.md) ‚Äî pricing, revenue
2. [Competitive Analysis](docs/discovery/competitive-analysis.md) ‚Äî market gaps
3. [Legal/Compliance](docs/discovery/legal/) ‚Äî risks
4. [Metrics Framework](docs/analytics/metrics-framework.md) ‚Äî KPIs

**üë®‚Äçüíª Tech Architect**
1. [LangGraph Architecture](docs/discovery/technical/langraph-architecture.md) ‚Äî multi-agent design
2. [API Integrations](docs/discovery/technical/api-integrations.md) ‚Äî integration catalog
3. [Kubernetes Infrastructure](docs/discovery/technical/kubernetes-infrastructure.md) ‚Äî deployment
4. [Requirements (FURPS+)](docs/business/requirements-furps.md) ‚Äî technical specs

**üé® Design & UX**
1. [UX Research](docs/discovery/ux-research.md) ‚Äî user insights
2. [User Flows](docs/design/user-flows.md) ‚Äî information architecture
3. [Customer Journey Map](docs/design/cjm.md) ‚Äî CJM by persona
4. [Personas](docs/discovery/personas.md) ‚Äî detailed personas

**üìä Analyst / Marketing**
1. [Metrics Framework](docs/analytics/metrics-framework.md) ‚Äî KPIs
2. [Tracking Plan](docs/analytics/tracking-plan.md) ‚Äî event taxonomy
3. [Marketing Strategy](docs/marketing/strategy.md) ‚Äî GTM
4. [Competitive Analysis](docs/discovery/competitive-analysis.md) ‚Äî market positioning

---

## üìñ –†–ï–ö–û–ú–ï–ù–î–£–ï–ú–´–ô –ü–û–†–Ø–î–û–ö –ß–¢–ï–ù–ò–Ø

### üü¢ –î–ª—è –Ω–æ–≤—ã—Ö —á–ª–µ–Ω–æ–≤ –∫–æ–º–∞–Ω–¥—ã (2-3 —á–∞—Å–∞)

1. **[Project Brief Summary](context/summaries/project-brief-summary.md)** (5 –º–∏–Ω)
2. **[Vision Statement](docs/discovery/vision.md)** (20 –º–∏–Ω)
3. **[PRD Summary](context/summaries/prd-summary.md)** (10 –º–∏–Ω)
4. **[Personas Summary](context/summaries/personas-summary.yaml)** (5 –º–∏–Ω)
5. **[Business Model Summary](context/summaries/business-model-summary.md)** (10 –º–∏–Ω)
6. –í—ã–±–µ—Ä–∏—Ç–µ —Å–≤–æ—é —Ä–æ–ª—å –∏ —É–≥–ª—É–±–∏—Ç–µ—Å—å –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–µ docs (30-60 –º–∏–Ω)

### üü° –î–ª—è –≤–ª—É–±–ª–µ–Ω–Ω–æ–≥–æ –∏–∑—É—á–µ–Ω–∏—è (8-12 —á–∞—Å–æ–≤)

–ü—Ä–æ—á–∏—Ç–∞–π—Ç–µ **–≤—Å–µ Primary Documents (18)** –≤ –ø–æ—Ä—è–¥–∫–µ:
1. Project Brief + Summaries (30 –º–∏–Ω)
2. Vision + PRD + User Stories (2 —á–∞—Å–∞)
3. Business + Legal (1.5 —á–∞—Å–∞)
4. Technical Architecture (1.5 —á–∞—Å–∞)
5. UX + Design (1 —á–∞—Å)
6. Analytics + Marketing (1 —á–∞—Å)
7. Competitive Analysis + Research (2 —á–∞—Å–∞)

### üî¥ –î–ª—è —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã (–ø–æ–ª–Ω–æ–µ –∏–∑—É—á–µ–Ω–∏–µ)

–ü—Ä–æ—á–∏—Ç–∞–π—Ç–µ **–≤—Å–µ 32 –¥–æ–∫—É–º–µ–Ω—Ç–∞** (Discovery Completion Report + Checkpoints):
- Primary Documents: ~5,500 lines
- Summaries: ~500 lines
- Checkpoints: ~800 lines
- **Total**: ~6,800 lines (8-12 —á–∞—Å–æ–≤)

---

## üìù –ö–û–ù–¢–ï–ö–°–¢–ù–´–ï –†–ï–ó–Æ–ú–ï

–í—Å–µ —Ä–µ–∑—é–º–µ –Ω–∞—Ö–æ–¥—è—Ç—Å—è –≤ `/context/summaries/` –¥–ª—è –±—ã—Å—Ç—Ä–æ–≥–æ –æ–∑–Ω–∞–∫–æ–º–ª–µ–Ω–∏—è:

```
üìÅ context/summaries/
‚îú‚îÄ‚îÄ project-brief-summary.md ............. 54 lines (1 liner, innovations)
‚îú‚îÄ‚îÄ prd-summary.md ....................... 75 lines (exec summary)
‚îú‚îÄ‚îÄ personas-summary.yaml ............... 50 lines (3 personas overview)
‚îú‚îÄ‚îÄ requirements-furps-summary.yaml ...... 60 lines (218 reqs breakdown)
‚îú‚îÄ‚îÄ metrics-framework-summary.yaml ....... 50 lines (key metrics)
‚îú‚îÄ‚îÄ roadmap-summary.yaml ................. 40 lines (phases & timelines)
‚îú‚îÄ‚îÄ use-cases-summary.yaml ............... 50 lines (key use cases)
‚îú‚îÄ‚îÄ ux-research-summary.yaml ............. 50 lines (research findings)
‚îî‚îÄ‚îÄ business-model-summary.md ........... 55 lines (revenue model)

Total: ~505 lines (perfect for 30-45 minute read)
```

---

## üîñ CHECKPOINTS –ò PROGRESS TRACKING

–§–∞–∑–æ–≤—ã–µ –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω—ã–µ —Ç–æ—á–∫–∏ –Ω–∞—Ö–æ–¥—è—Ç—Å—è –≤ `/context/checkpoints/`:

```
üìÅ context/checkpoints/
‚îú‚îÄ‚îÄ 2026-01-26-requirements-furps.md ............... FURPS+ requirements checkpoint
‚îú‚îÄ‚îÄ 2026-01-26-tracking-plan.md ................... Metrics & tracking checkpoint
‚îú‚îÄ‚îÄ 2026-01-26-use-cases.md ....................... Use cases checkpoint
‚îú‚îÄ‚îÄ 2026-01-26-ux-research.md ..................... UX research findings checkpoint
‚îî‚îÄ‚îÄ 2026-01-26-discovery-phase-complete.md ........ **FINAL PHASE COMPLETION** ‚úÖ
```

**Reference**: [DISCOVERY_COMPLETION_REPORT.md](DISCOVERY_COMPLETION_REPORT.md)

---

## ‚öôÔ∏è TECH STACK

### Backend
- **API Gateway**: FastAPI + Kong
- **Agent Orchestrator**: LangGraph / CrewAI
- **RAG Pipeline**: LlamaIndex + Qdrant
- **Databases**: PostgreSQL (profiles), ClickHouse/TimescaleDB (time-series), Qdrant (vectors), Neo4j (graph)
- **Cache**: Redis
- **Queue**: Kafka / RabbitMQ
- **ML Platform**: MLflow + PyTorch

### Frontend
- **Mobile**: Flutter (iOS + Android)
- **Web**: Next.js + Tailwind
- **Telegram**: aiogram 3.x
- **Voice**: Whisper + TTS

### LLM Providers
- **International**: OpenAI GPT-4o, Anthropic Claude
- **Russian**: GigaChat, YandexGPT
- **Medical**: Med-PaLM 2, BioMistral
- **Embeddings**: text-embedding-3-large, e5-mistral-7b

---

## üí∞ BUSINESS MODEL

### Pricing Tiers

| Tier | Price | Features | Target |
|------|-------|----------|--------|
| **Free** | 0 ‚ÇΩ | –ë–∞–∑–æ–≤—ã–π Health Score, 1 –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è, 10 –∑–∞–ø—Ä–æ—Å–æ–≤/–¥–µ–Ω—å | Lead generation |
| **Optimize** | 990 ‚ÇΩ/–º–µ—Å | –í—Å–µ wearables, 5 –∞–≥–µ–Ω—Ç–æ–≤, 100 –∑–∞–ø—Ä–æ—Å–æ–≤/–¥–µ–Ω—å | Health Optimizers |
| **Biohacker Pro** | 2,490 ‚ÇΩ/–º–µ—Å | –í—Å–µ –∞–≥–µ–Ω—Ç—ã, Custom RAG 5GB, –±–µ–∑–ª–∏–º–∏—Ç | Advanced Biohackers |
| **Longevity Elite** | 9,990 ‚ÇΩ/–º–µ—Å | –≠–ø–∏–≥–µ–Ω–µ—Ç–∏–∫–∞, RAG 50GB, API, –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–∏ | Longevity Focused |
| **Enterprise** | Custom | White-label, On-premise, SLA | B2B/Corporate |

### Revenue Streams
1. üí≥ **Subscription** ‚Äî Primary revenue (90%)
2. üè™ **Marketplace** ‚Äî 10-15% commission on supplements
3. üß¨ **Lab Referrals** ‚Äî 5-8% affiliate on tests
4. üìö **Premium Protocols** ‚Äî Sell curated protocols
5. üè¢ **B2B/Corporate** ‚Äî White-label wellness programs

**Projections M12**: MRR 15M ‚ÇΩ, LTV/CAC 5x

---

## ‚úÖ DISCOVERY PHASE COMPLETION

**Status**: ‚úÖ **QUALITY GATE PASSED** (10/10 criteria)

**Deliverables**: 32 artifacts (18 primary + 9 summaries + 5 checkpoints)

**Quality Metrics**:
- ‚úÖ Requirements: 218 (P0: 156, P1: 56)
- ‚úÖ User Stories: 21 (all with AC in Gherkin)
- ‚úÖ AI Agents: 15 mapped and documented
- ‚úÖ API Integrations: 100+ catalog
- ‚úÖ Competitors: 8 analyzed
- ‚úÖ Critical Blockers: 0

**Recommendation**: ‚úÖ **PROCEED TO DESIGN PHASE**

**Next Phase**: DESIGN (6 weeks, est. 2026-02-23 sign-off)

---

## üìö –î–û–ö–£–ú–ï–ù–¢–ê–¶–ò–Ø –ü–û –ê–°–ü–ï–ö–¢–ê–ú

### üõ°Ô∏è –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ Compliance

- [152-–§–ó Compliance](docs/discovery/legal/152-fz-compliance.md) ‚Äî –†–æ—Å—Å–∏–π—Å–∫–æ–µ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ
- [Wellness vs Medicine](docs/discovery/legal/wellness-vs-medicine.md) ‚Äî –ü—Ä–∞–≤–æ–≤—ã–µ –≥—Ä–∞–Ω–∏—Ü—ã
- [Legal Summary](docs/discovery/legal/legal-summary.md) ‚Äî Risk assessment
- [Disclaimers Templates](docs/discovery/legal/disclaimers-templates.md) ‚Äî Ready-to-use templates

### üîó –ò–Ω—Ç–µ–≥—Ä–∞—Ü–∏–∏ (100+ API)

**–ö–∞—Ç–µ–≥–æ—Ä–∏–∏**:
- üì± **Wearables**: Oura, Apple Watch, WHOOP, Garmin, Fitbit
- üìä **CGM**: Dexcom, Libre, Levels
- üß™ **Labs (RU)**: INVITRO, Helix, CMD, –ì–µ–º–æ—Ç–µ—Å—Ç
- üß¨ **Genomics**: 23andMe, Ancestry, Nebula
- ü¶† **Microbiome**: Viome, ZOE, Atlas
- üçΩÔ∏è **Nutrition**: MyFitnessPal, Cronometer

**–î–µ—Ç–∞–ª—å–Ω—ã–π –∫–∞—Ç–∞–ª–æ–≥**: [API Integrations](docs/discovery/technical/api-integrations.md)

### üìä –ê–Ω–∞–ª–∏—Ç–∏–∫–∞ –∏ –ú–µ—Ç—Ä–∏–∫–∏

**Framework**: AARRR (Acquisition, Activation, Retention, Revenue, Referral)

**Key Metrics**:
- DAU/MAU ratio > 30%
- AI queries per user > 5/week
- Free ‚Üí Paid conversion > 5%
- Paid retention (M3) > 70%
- NPS > 50

**–î–æ–∫—É–º–µ–Ω—Ç—ã**: [Metrics Framework](docs/analytics/metrics-framework.md) + [Tracking Plan](docs/analytics/tracking-plan.md)

---

## üéØ –ö–õ–Æ–ß–ï–í–´–ï –†–ï–®–ï–ù–ò–Ø (2026-01-26)

| –†–µ—à–µ–Ω–∏–µ | –í—ã–±–æ—Ä | –û–±–æ—Å–Ω–æ–≤–∞–Ω–∏–µ |
|---------|-------|-----------|
| **Platform Priority** | Telegram Bot ‚Üí WebApp ‚Üí Flutter | Time-to-market —á–µ—Ä–µ–∑ Telegram |
| **Target Market** | Russia (primary) | 152-–§–ó compliance, local labs, GigaChat |
| **MVP Scope** | Max modules + 1 integration each | –î–µ–º–æ–Ω—Å—Ç—Ä–∞—Ü–∏—è –ø–æ–ª–Ω–æ—Ç—ã –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã |
| **Infrastructure** | Self-hosted Kubernetes | –ö–æ–Ω—Ç—Ä–æ–ª—å –¥–∞–Ω–Ω—ã—Ö, 152-–§–ó, –≥–∏–±–∫–æ—Å—Ç—å |
| **Partnerships** | Landing Page –¥–ª—è –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—è | –ù—É–∂–Ω–∞ –¥–ª—è outreach –∫ –ø–∞—Ä—Ç–Ω—ë—Ä–∞–º |

---

## üö® –†–ò–°–ö–ò –ò –°–ú–Ø–ì–ß–ï–ù–ò–ï

| –†–∏—Å–∫ | –í–µ—Ä–æ—è—Ç–Ω–æ—Å—Ç—å | –í–æ–∑–¥–µ–π—Å—Ç–≤–∏–µ | –°–º—è–≥—á–µ–Ω–∏–µ |
|------|-------------|------------|----------|
| **Regulatory Constraints** | High | High | Wellness positioning, disclaimers |
| **Data Security Breach** | Medium | **CRITICAL** | E2E encryption, 152-–§–ó, SOC2 |
| **AI Hallucinations** | Medium | High | RAG + safety agent, human-in-loop |
| **Low Conversion F‚ÜíP** | High | Medium | Value demo, trials, gamification |
| **BigTech Competition** | High | High | Advanced biohackers focus, RU market |

**–ü–æ–ª–Ω—ã–π –∞–Ω–∞–ª–∏–∑**: [Legal Summary](docs/discovery/legal/legal-summary.md) & [DISCOVERY_COMPLETION_REPORT.md](DISCOVERY_COMPLETION_REPORT.md)

---

## üìû –ö–û–ù–¢–ê–ö–¢–´ –ò –ü–û–î–î–ï–†–ñ–ö–ê

**Project Lead**: Orchestrator Agent  
**Documentation**: Last updated 2026-01-26  
**Status**: Discovery Complete ‚úÖ ‚Üí Design Phase Ready üé®

---

## üìÑ –õ–∏—Ü–µ–Ω–∑–∏—è

MIT License ‚Äî –∏—Å–ø–æ–ª—å–∑—É–π—Ç–µ –∏ –∞–¥–∞–ø—Ç–∏—Ä—É–π—Ç–µ —Å–≤–æ–±–æ–¥–Ω–æ.

---

## üôè –ë–ª–∞–≥–æ–¥–∞—Ä–Ω–æ—Å—Ç–∏

–°–ø–∞—Å–∏–±–æ –≤—Å–µ–º —É—á–∞—Å—Ç–Ω–∏–∫–∞–º Discovery —Ñ–∞–∑—ã:
- **Product Team** ‚Äî Vision, PRD, User Stories
- **Research Team** ‚Äî Competitive analysis, market research
- **Business Team** ‚Äî Business model, requirements
- **Technical Team** ‚Äî Architecture, integrations
- **Legal Team** ‚Äî Compliance, regulatory framework
- **UX Team** ‚Äî User research, flows, accessibility
- **Analytics Team** ‚Äî Metrics, tracking plan
- **Orchestrator** ‚Äî Coordination and quality gates

---

**–ü–æ—Å–ª–µ–¥–Ω–µ–µ –æ–±–Ω–æ–≤–ª–µ–Ω–∏–µ**: 26 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞  
**–°—Ç–∞—Ç—É—Å**: ‚úÖ DISCOVERY PHASE COMPLETE | üé® DESIGN PHASE READY
